https://www.s-cubed-global.com/news/clinical-data-publication 2024-02-01T14:54:07+00:00 https://www.s-cubed-global.com/wp-content/uploads/2024/01/clinical-data-publication.jpg https://www.s-cubed-global.com/wp-content/uploads/2024/01/policy-70.jpg https://www.s-cubed-global.com/regulatory-affairs/q4-2023-newsletter-whats-new-in-clinical-development-practices-regulations 2024-02-01T14:59:00+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/12/q4-2023.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/12/q4-23-page-banner.jpg https://www.s-cubed-global.com/articles/clinical-trial-legislation-in-the-uk 2024-02-01T15:10:19+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/11/clinical-trial-legislation-1.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/11/clinical-trial-legislation.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/11/Initial-review-application-process-timelines.png https://www.s-cubed-global.com/ema/free-portfolio-and-technology-meeting-with-the-ema 2024-02-01T15:13:32+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/10/portfolio-technology-meeting-ema.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/10/ema-meeting.jpg https://www.s-cubed-global.com/regulatory-affairs/ema-revised-transparency-rules-for-ctis 2024-02-01T15:15:15+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/10/clinical-trial.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/10/clinical-trials.jpg https://www.s-cubed-global.com/news/implementation-of-the-windsor-framework 2024-02-01T15:17:43+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/10/windsor-framework.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/06/news-windsor-framework.jpg https://www.s-cubed-global.com/news/the-future-of-orphan-medicines-in-the-eu 2024-02-01T15:19:13+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/10/orphan-medicine.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/10/news-orphan-medicine.jpg https://www.s-cubed-global.com/uncategorised/q3-2023-newsletter-whats-new-in-clinical-development-practices-regulations 2024-02-01T15:21:36+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/09/q3-2023.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/09/q3-23-page-banner.jpg https://www.s-cubed-global.com/ema/draft-ema-reflection-paper-on-artificial-intelligence 2024-02-01T15:24:25+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/08/draft-ema.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/08/news-ai-head.jpg https://www.s-cubed-global.com/news/s-cubed-denmark-aps-acquired-by-phastar 2024-02-01T16:05:43+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/07/phastar-logo.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/05/phastar-news-head.jpg https://www.s-cubed-global.com/news/ema-open-initiative-extended-scope 2024-02-01T16:51:38+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/07/flags.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/07/flags_03.jpg https://www.s-cubed-global.com/industry-insights/windsor-framework 2024-02-01T16:54:04+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/06/windsor-framework.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/06/news-windsor-framework.jpg https://www.s-cubed-global.com/news/edqm-launches-cep-2-0 2024-02-01T16:58:41+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/05/edqm.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/05/edqm-in.jpg https://www.s-cubed-global.com/regulatory-affairs/q2-2023-newsletter-whats-new-in-clinical-development-practices-regulations 2024-02-01T17:03:04+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/05/q2-2023.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/05/q2-23-page-banner-1.jpg https://www.s-cubed-global.com/news/1st-dec-2022-launch-of-phase-2-of-the-simultaneous-national-scientific-advice-snsa-pilot 2024-02-01T17:35:26+00:00 https://www.s-cubed-global.com/wp-content/uploads/2022/12/hma.jpg https://www.s-cubed-global.com/wp-content/uploads/2022/12/hma-logo.png https://www.s-cubed-global.com/regulatory-affairs/regulations-fda-guidelines-clinical-trial-data-q4-2022 2024-02-02T09:41:01+00:00 https://www.s-cubed-global.com/wp-content/uploads/2022/12/q4-2022.jpg https://www.s-cubed-global.com/wp-content/uploads/2022/12/q4-page-banner.png https://www.s-cubed-global.com/regulatory-affairs/q1-2023-newsletter-whats-new-in-clinical-development-practices-regulations 2024-02-02T09:41:45+00:00 https://www.s-cubed-global.com/wp-content/uploads/2022/12/lab1.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/02/q1-23-page-banner-1.jpg https://www.s-cubed-global.com/news/cdisc-interchange-europe-virtual-world 2024-02-02T09:48:39+00:00 https://www.s-cubed-global.com/wp-content/uploads/2022/09/cdisc.jpg https://www.s-cubed-global.com/wp-content/uploads/2021/03/cdisc-interchange-header.jpg https://www.s-cubed-global.com/wp-content/uploads/CDISC-Membership-Badge-Proud-Member-300x100.png https://www.s-cubed-global.com/regulatory-affairs/regulations-inspections-initiatives-across-the-world-rwd-rwe 2024-02-02T09:49:10+00:00 https://www.s-cubed-global.com/wp-content/uploads/2022/12/vials.jpg https://www.s-cubed-global.com/wp-content/uploads/2022/09/q3banner.png https://www.s-cubed-global.com/news/titanium-dioxide-in-medicinal-products 2024-02-02T09:49:55+00:00 https://www.s-cubed-global.com/wp-content/uploads/2022/08/pills.jpg https://www.s-cubed-global.com/wp-content/uploads/2022/07/titanium-dioxide-panel-2022.jpg https://www.s-cubed-global.com/regulatory-affairs/proposed-ema-fee-regulation 2024-02-21T12:43:10+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/12/proposed-ema-fee-regulation.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/12/ema-fee-regulation.jpg https://www.s-cubed-global.com/industry-insights/q1-2024-newsletter-whats-new-in-clinical-development-practices-regulations 2024-03-06T12:01:57+00:00 https://www.s-cubed-global.com/wp-content/uploads/2024/03/newsletter-q1-24-list-1.jpg https://www.s-cubed-global.com/wp-content/uploads/2024/03/newsletter-q1-24.jpg https://www.s-cubed-global.com/regulatory-affairs/proposal-to-amend-mdr-and-ivdr 2024-03-13T10:44:12+00:00 https://www.s-cubed-global.com/wp-content/uploads/2024/03/amend-mdr-ivdr-1.jpg https://www.s-cubed-global.com/wp-content/uploads/2024/03/amend-mdr-ivdr-2.jpg https://www.s-cubed-global.com/ema/clinical-data-publication-2 2024-04-03T13:47:50+00:00 https://www.s-cubed-global.com/wp-content/uploads/2024/04/Clinical-Data-Publication-sm.jpg https://www.s-cubed-global.com/wp-content/uploads/2024/04/Clinical-Data-Publication.jpg https://www.s-cubed-global.com/industry-insights/q2-2024-newsletter-whats-new-in-clinical-development-practices-regulations 2024-05-16T08:33:04+00:00 https://www.s-cubed-global.com/wp-content/uploads/2024/03/newsletter-q1-24-list-1.jpg https://www.s-cubed-global.com/wp-content/uploads/2024/05/newsletter-q2-24.jpg https://www.s-cubed-global.com/industry-insights/q3-2024-newsletter-whats-new-in-clinical-development-practices-regulations 2024-08-27T10:43:06+00:00 https://www.s-cubed-global.com/wp-content/uploads/2024/03/newsletter-q1-24-list-1.jpg https://www.s-cubed-global.com/wp-content/uploads/2024/08/q3-24-page-banner.jpg https://www.s-cubed-global.com/news/ema-new-fee-regulation 2024-11-12T12:36:52+00:00 https://www.s-cubed-global.com/wp-content/uploads/2023/12/proposed-ema-fee-regulation.jpg https://www.s-cubed-global.com/wp-content/uploads/2023/12/ema-fee-regulation.jpg https://www.s-cubed-global.com/industry-insights/q4-2024-newsletter-whats-new-in-clinical-development-practices-regulations 2024-12-17T09:35:36+00:00 https://www.s-cubed-global.com/wp-content/uploads/2024/03/newsletter-q1-24-list-1.jpg https://www.s-cubed-global.com/wp-content/uploads/2024/12/q4-24-page-banner.jpg https://www.s-cubed-global.com/news/s-cubed-ltd-is-excited-to-announce-that-it-has-joined-the-athagoras-group 2025-01-30T11:27:33+00:00 https://www.s-cubed-global.com/wp-content/uploads/2025/01/athagoras-logo.png https://www.s-cubed-global.com/wp-content/uploads/2025/01/athagoras-logo-lrg.png https://www.s-cubed-global.com/data-analytics/emas-data-management-services 2025-02-05T17:12:08+00:00 https://www.s-cubed-global.com/wp-content/uploads/2025/02/spor-article.jpg https://www.s-cubed-global.com/wp-content/uploads/2025/02/spor-article-2.jpg https://www.s-cubed-global.com/industry-insights/q1-2025-newsletter-whats-new-in-clinical-development-practices-regulations 2025-02-25T09:53:24+00:00 https://www.s-cubed-global.com/wp-content/uploads/2025/02/newsletter-list25.jpg https://www.s-cubed-global.com/wp-content/uploads/2025/02/q1-25-page-banner.jpg https://www.s-cubed-global.com/news/the-innovative-licensing-and-access-pathway-ilap-in-the-uk 2025-04-08T14:50:56+00:00 https://www.s-cubed-global.com/wp-content/uploads/2025/04/AdobeStock_961347470-scaled.jpeg https://www.s-cubed-global.com/industry-insights/q2-2025-newsletter-whats-new-in-clinical-development-practices-regulations 2025-05-14T16:13:37+00:00 https://www.s-cubed-global.com/wp-content/uploads/2025/02/newsletter-list25.jpg https://www.s-cubed-global.com/wp-content/uploads/2025/05/q2-25-page-banner.jpg https://www.s-cubed-global.com/regulatory-affairs/prime-at-the-ema 2025-07-22T13:28:06+00:00 https://www.s-cubed-global.com/wp-content/uploads/2025/07/news-prime-1.jpg https://www.s-cubed-global.com/industry-insights/q3-2025-newsletter-whats-new-in-clinical-development-practices-regulations 2025-08-28T08:03:33+00:00 https://www.s-cubed-global.com/wp-content/uploads/2025/02/newsletter-list25.jpg https://www.s-cubed-global.com/wp-content/uploads/2025/08/q3-25-page-banner.jpg https://www.s-cubed-global.com/uncategorised/orphan-medicinal-products-in-the-eu 2025-11-11T14:58:01+00:00 https://www.s-cubed-global.com/wp-content/uploads/2025/11/orphan-medicines.jpg https://www.s-cubed-global.com/wp-content/uploads/2025/11/orphan-medicines-1.jpg https://www.s-cubed-global.com/industry-insights/q4-2025-newsletter-whats-new-in-clinical-development-practices-regulations 2025-11-28T14:43:15+00:00 https://www.s-cubed-global.com/wp-content/uploads/2025/02/newsletter-list25.jpg https://www.s-cubed-global.com/wp-content/uploads/2025/11/q4-25-page-banner.jpg https://www.s-cubed-global.com/industry-insights/q1-2026-newsletter-whats-new-in-clinical-development-practices-regulations 2026-03-12T09:45:23+00:00 https://www.s-cubed-global.com/wp-content/uploads/2026/03/Industry-Insights-26.jpg https://www.s-cubed-global.com/wp-content/uploads/2026/03/q1-26-page-banner.jpg https://www.s-cubed-global.com/regulatory-affairs/aligned-pathway 2026-04-28T14:09:25+00:00 https://www.s-cubed-global.com/wp-content/uploads/2025/10/blister-packs.jpg https://www.s-cubed-global.com/wp-content/uploads/2025/10/tablets.jpg https://www.s-cubed-global.com/news/antimicrobial-resistance 2026-04-28T14:10:23+00:00 https://www.s-cubed-global.com/wp-content/uploads/2026/01/Antimicrobial-resistance-1.jpg https://www.s-cubed-global.com/wp-content/uploads/2026/01/Antimicrobial-resistance-2.jpg https://www.s-cubed-global.com/news/new-uk-clinical-trial-regulations 2026-04-28T14:10:43+00:00 https://www.s-cubed-global.com/wp-content/uploads/2026/01/news-clinical-trial-regulations-1.jpg https://www.s-cubed-global.com/wp-content/uploads/2026/01/news-clinical-trial-regulations-2.jpg https://www.s-cubed-global.com/news/new-uk-clinical-trial-regulations-transition 2026-04-28T14:11:06+00:00 https://www.s-cubed-global.com/wp-content/uploads/2026/01/news-clinical-trial-regulations-1.jpg https://www.s-cubed-global.com/wp-content/uploads/2026/01/news-clinical-trial-regulations-2.jpg https://www.s-cubed-global.com/news/eu-paediatric-investigation-plan-mechanism-of-action 2026-04-28T14:11:36+00:00 https://www.s-cubed-global.com/wp-content/uploads/2026/02/news-clinical-trials-children.jpg https://www.s-cubed-global.com/uncategorised/ich-m4qr2-common-technical-document-quality-guideline 2026-04-28T14:11:56+00:00 https://www.s-cubed-global.com/wp-content/uploads/2026/03/news-ICH-M4Q-R2.jpg https://www.s-cubed-global.com/news/medical-device-and-in-vitro-diagnostics-regulations 2026-05-19T11:48:25+00:00 https://www.s-cubed-global.com/wp-content/uploads/2026/05/medical-device-news-3.jpg https://www.s-cubed-global.com/wp-content/uploads/2026/05/medical-device-news-4.jpg https://www.s-cubed-global.com/news/edqm-publishes-new-guidance-on-reliance-based-and-fast-track-assessment-of-cep-applications 2026-06-03T11:36:33+00:00 https://www.s-cubed-global.com/wp-content/uploads/2026/06/news-certificate.jpg https://www.s-cubed-global.com/news/revision-to-the-guideline-on-the-chemistry-of-active-substances 2026-08-26T15:52:11+00:00 https://www.s-cubed-global.com/wp-content/uploads/2026/04/news-active-substances-1.jpg https://www.s-cubed-global.com/news/new-uk-regulation-framework-for-rare-diseases 2026-08-27T12:04:39+00:00 https://www.s-cubed-global.com/wp-content/uploads/2026/08/news-gavel.jpg https://www.s-cubed-global.com/wp-content/uploads/2026/08/news-gavel.jpg https://www.s-cubed-global.com/industry-insights/q2-2026-newsletter-whats-new-in-clinical-development-practices-regulations 2026-09-30T10:27:16+00:00 https://www.s-cubed-global.com/wp-content/uploads/2026/03/Industry-Insights-26.jpg https://www.s-cubed-global.com/industry-insights/q3-2026-newsletter-whats-new-in-pharmaceutical-and-medical-device-regulations 2026-09-30T12:13:44+00:00 https://www.s-cubed-global.com/wp-content/uploads/2026/03/Industry-Insights-26.jpg https://www.s-cubed-global.com/wp-content/uploads/2026/09/q3-26-page-banner.jpg